Suppr超能文献

美国早期非小细胞肺癌微创手术和立体定向体部放疗的应用:基于国家癌症数据库的时间趋势生态学研究。

Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer Database.

机构信息

Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands

Guest affiliation for this project with Division of Pulmonary & Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, United States.

出版信息

BMJ Open Respir Res. 2020 May;7(1). doi: 10.1136/bmjresp-2020-000603.

Abstract

BACKGROUND

We aimed to assess the uptake of minimally invasive surgery (MIS) and stereotactic body radiation therapy (SBRT) among early stage (stage IA-IIB) non-small cell lung cancer (NSCLC) cases in the USA, and the rate of conversions from MIS to open surgery.

MATERIALS AND METHODS

Data were obtained from the US National Cancer Database, a nationwide facility-based cancer registry capturing up to 70% of incident cancer cases in the USA. We included cases diagnosed with early stage (clinical stages IA-IIB) NSCLC between 2010 and 2014. In an ecological analysis, we assessed changes in treatment by year of diagnosis. Among surgically treated cases, we assessed the uptake of MIS and whether conversion to open surgery took place. For cases that received thoracic radiotherapy, we assessed the uptake of SBRT.

RESULTS

Among 117 370 selected cases, radiotherapy use increased 3.4 percentage points between 2010 and 2014 (p<0.0001). Surgical treatments decreased 3.5 percentage points (p<0.0001). Rates of non-treatment remained stable (range: 10.0%-10.6% (p=0.4066)). Among surgically treated stage IA cases, uptake of MIS increased from 28.7% (95% CI 27.8% to 29.7%) in 2010 to 48.6% (95% CI 47.6% to 49.6%) in 2014 (p<0.0001), while conversions decreased from 17.0% (95% CI 15.6% to 18.6%) in 2010 to 9.1% (95% CI 8.3% to 10.0%) in 2014 (p<0.0001). MIS uptake among stages IB-IIB was lower and conversion rates were higher, but time trends were similar. Uptake of SBRT among stage IA receiving thoracic radiotherapy increased from 53.4% (95% CI 51.2% to 55.6%) in 2010 to 73.0% (95% CI 71.4% to 74.6%) in 2014 (p<0.0001). SBRT uptake among stage IB increased from 32.5% (95% CI 29.9% to 35.2%) in 2010 to 48.2% (95% CI 45.6% to 50.8%) in 2014 (p<0.0001).

CONCLUSION

Between 2010 and 2014, uptake of MIS and SBRT among early stage NSCLC significantly increased, while the rate of conversions to open surgery significantly decreased. Continuing these trends may contribute to improving patient care, in particular with the expected increase in early stages due to the implementation of lung cancer screening.

摘要

背景

我们旨在评估美国早期(IA-IIB 期)非小细胞肺癌(NSCLC)病例中微创外科(MIS)和立体定向体放射治疗(SBRT)的应用情况,以及从 MIS 转为开放手术的比例。

材料和方法

数据来自美国国家癌症数据库,这是一个全国性的基于设施的癌症登记处,可捕获美国多达 70%的新发癌症病例。我们纳入了 2010 年至 2014 年间诊断为早期(临床分期 IA-IIB)NSCLC 的病例。在生态分析中,我们评估了每年诊断时治疗方式的变化。在接受手术治疗的病例中,我们评估了 MIS 的应用情况以及是否发生了转为开放手术的情况。对于接受胸部放疗的病例,我们评估了 SBRT 的应用情况。

结果

在 117370 例选定病例中,放疗使用率在 2010 年至 2014 年间增加了 3.4 个百分点(p<0.0001)。手术治疗减少了 3.5 个百分点(p<0.0001)。未治疗的比例保持稳定(范围:10.0%-10.6%(p=0.4066))。在接受手术治疗的 IA 期病例中,MIS 的应用率从 2010 年的 28.7%(95%CI 27.8%至 29.7%)增加到 2014 年的 48.6%(95%CI 47.6%至 49.6%)(p<0.0001),而转化率从 2010 年的 17.0%(95%CI 15.6%至 18.6%)降至 2014 年的 9.1%(95%CI 8.3%至 10.0%)(p<0.0001)。IB-IIB 期的 MIS 应用率较低,转化率较高,但时间趋势相似。接受胸部放疗的 IA 期患者中 SBRT 的应用率从 2010 年的 53.4%(95%CI 51.2%至 55.6%)增加到 2014 年的 73.0%(95%CI 71.4%至 74.6%)(p<0.0001)。IB 期的 SBRT 应用率从 2010 年的 32.5%(95%CI 29.9%至 35.2%)增加到 2014 年的 48.2%(95%CI 45.6%至 50.8%)(p<0.0001)。

结论

2010 年至 2014 年间,早期 NSCLC 中 MIS 和 SBRT 的应用率显著增加,而转为开放手术的比例显著下降。继续保持这些趋势可能有助于改善患者的护理,特别是随着肺癌筛查的实施,预计早期病例会增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6064/7228566/67c9cf4b53eb/bmjresp-2020-000603f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验